IRS in sex-change surgery debate
The American tax office has been dragged into the debate over whether sex-changes are genuine medical treatment or an inappropriate response to a psychological problem. Rhianon O’Donnabhain, a construction engineer from Boston, decided to become a woman in 2001 after having fathered three children. He claimed a US$5,000 tax deduction for the surgery, which the Internal Revenue Service initially allowed. However, the IRS quickly reversed its decision because the operation had been merely cosmetic, and therefore not deductible. O’Donnabhain refused and sued the IRS. The case is now making its way through the courts.
O’Donnabhain, now 64, is supported by the Boston-based Gay and Lesbian Advocates and Defenders as a test case. A psychiatrist at Harvard Medical School, Marshall Forstein, says that an operation is clearly medically necessary. “When did the IRS suddenly become physicians? It’s absolutely clear that transgender identity is a condition discussed in diagnostic manuals. It seems the IRS is now in the business of practicing medicine without a licence.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...